Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation.

Poliseno L, Salmena L, Riccardi L, Fornari A, Song MS, Hobbs RM, Sportoletti P, Varmeh S, Egia A, Fedele G, Rameh L, Loda M, Pandolfi PP.

Sci Signal. 2010 Apr 13;3(117):ra29. doi: 10.1126/scisignal.2000594. Erratum in: Sci Signal. 2010;3(123):er6.

2.

Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia.

Mavrakis KJ, Wolfe AL, Oricchio E, Palomero T, de Keersmaecker K, McJunkin K, Zuber J, James T, Khan AA, Leslie CS, Parker JS, Paddison PJ, Tam W, Ferrando A, Wendel HG.

Nat Cell Biol. 2010 Apr;12(4):372-9. doi: 10.1038/ncb2037. Epub 2010 Feb 28.

3.

Monoallelic but not biallelic loss of Dicer1 promotes tumorigenesis in vivo.

Lambertz I, Nittner D, Mestdagh P, Denecker G, Vandesompele J, Dyer MA, Marine JC.

Cell Death Differ. 2010 Apr;17(4):633-41. doi: 10.1038/cdd.2009.202. Epub 2009 Dec 18.

4.

miR-19 is a key oncogenic component of mir-17-92.

Olive V, Bennett MJ, Walker JC, Ma C, Jiang I, Cordon-Cardo C, Li QJ, Lowe SW, Hannon GJ, He L.

Genes Dev. 2009 Dec 15;23(24):2839-49. doi: 10.1101/gad.1861409.

5.

Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas.

Mu P, Han YC, Betel D, Yao E, Squatrito M, Ogrodowski P, de Stanchina E, D'Andrea A, Sander C, Ventura A.

Genes Dev. 2009 Dec 15;23(24):2806-11. doi: 10.1101/gad.1872909.

6.

MicroRNA 92b controls the G1/S checkpoint gene p57 in human embryonic stem cells.

Sengupta S, Nie J, Wagner RJ, Yang C, Stewart R, Thomson JA.

Stem Cells. 2009 Jul;27(7):1524-8. doi: 10.1002/stem.84.

7.

miRanalyzer: a microRNA detection and analysis tool for next-generation sequencing experiments.

Hackenberg M, Sturm M, Langenberger D, Falcón-Pérez JM, Aransay AM.

Nucleic Acids Res. 2009 Jul;37(Web Server issue):W68-76. doi: 10.1093/nar/gkp347. Epub 2009 May 11.

8.

The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition.

Cloonan N, Brown MK, Steptoe AL, Wani S, Chan WL, Forrest AR, Kolle G, Gabrielli B, Grimmond SM.

Genome Biol. 2008;9(8):R127. doi: 10.1186/gb-2008-9-8-r127. Epub 2008 Aug 14.

9.

Cellular mechanisms of tumour suppression by the retinoblastoma gene.

Burkhart DL, Sage J.

Nat Rev Cancer. 2008 Sep;8(9):671-82. doi: 10.1038/nrc2399. Review.

PMID:
18650841
10.

Insights from mouse models into human retinoblastoma.

Macpherson D.

Cell Div. 2008 May 19;3:9. doi: 10.1186/1747-1028-3-9.

11.

miRiad roles for the miR-17-92 cluster in development and disease.

Mendell JT.

Cell. 2008 Apr 18;133(2):217-22. doi: 10.1016/j.cell.2008.04.001. Review.

12.

Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters.

Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ, Newman J, Bronson RT, Crowley D, Stone JR, Jaenisch R, Sharp PA, Jacks T.

Cell. 2008 Mar 7;132(5):875-86. doi: 10.1016/j.cell.2008.02.019.

13.

Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes.

Xiao C, Srinivasan L, Calado DP, Patterson HC, Zhang B, Wang J, Henderson JM, Kutok JL, Rajewsky K.

Nat Immunol. 2008 Apr;9(4):405-14. doi: 10.1038/ni1575. Epub 2008 Mar 9.

14.

miR-17-92 cluster accelerates adipocyte differentiation by negatively regulating tumor-suppressor Rb2/p130.

Wang Q, Li YC, Wang J, Kong J, Qi Y, Quigg RJ, Li X.

Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2889-94. doi: 10.1073/pnas.0800178105. Epub 2008 Feb 19.

15.

MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression.

Ivanovska I, Ball AS, Diaz RL, Magnus JF, Kibukawa M, Schelter JM, Kobayashi SV, Lim L, Burchard J, Jackson AL, Linsley PS, Cleary MA.

Mol Cell Biol. 2008 Apr;28(7):2167-74. doi: 10.1128/MCB.01977-07. Epub 2008 Jan 22.

16.

N-myc coordinates retinal growth with eye size during mouse development.

Martins RA, Zindy F, Donovan S, Zhang J, Pounds S, Wey A, Knoepfler PS, Eisenman RN, Roussel MF, Dyer MA.

Genes Dev. 2008 Jan 15;22(2):179-93. doi: 10.1101/gad.1608008.

17.
18.

Retinoblastoma: from the two-hit hypothesis to targeted chemotherapy.

MacPherson D, Dyer MA.

Cancer Res. 2007 Aug 15;67(16):7547-50. Review.

19.

One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma.

Corson TW, Gallie BL.

Genes Chromosomes Cancer. 2007 Jul;46(7):617-34. Review.

PMID:
17437278
20.

Neuronal differentiation and synaptogenesis in retinoblastoma.

Johnson DA, Zhang J, Frase S, Wilson M, Rodriguez-Galindo C, Dyer MA.

Cancer Res. 2007 Mar 15;67(6):2701-11.

Supplemental Content

Support Center